Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sinicco

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
The Journal of Antimicrobial Chemotherapy|January 11, 2007
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virusD Aguilar Marucco, L Veronese, D Gonzalez de Requena, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical settingD González de Requena, S Bonora, S Garazzino, et al.
Antiviral Therapy|August 1, 1996
A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infectionS Vella, A Lazzarin, G Carosi, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 1998
Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosisF Barchiesi, D Arzeni, M S Del Prete, et al.
European Journal of Epidemiology|May 8, 2001
Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values?P Pezzotti, A d'Arminio Monforte, R Bugarini, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2008
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferonD Aguilar Marucco, D Gonzalez de Requena, S Bonora, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1996
A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDSS Vella, M Floridia, L G Dally, et al.
The Journal of Infectious Diseases|February 1, 1997
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infectionM Floridia, S Vella, A C Seeber, et al.
Leukemia & Lymphoma|July 29, 2016
Hodgkin's Disease in 50 Intravenous Drug Users with HIV-InfectionS Monfardini, U Tirelli, E Vaccher, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
The Journal of Antimicrobial Chemotherapy|January 11, 2007
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virusD Aguilar Marucco, L Veronese, D Gonzalez de Requena, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical settingD González de Requena, S Bonora, S Garazzino, et al.
Antiviral Therapy|August 1, 1996
A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infectionS Vella, A Lazzarin, G Carosi, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 1998
Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosisF Barchiesi, D Arzeni, M S Del Prete, et al.
European Journal of Epidemiology|May 8, 2001
Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values?P Pezzotti, A d'Arminio Monforte, R Bugarini, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2008
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferonD Aguilar Marucco, D Gonzalez de Requena, S Bonora, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1996
A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDSS Vella, M Floridia, L G Dally, et al.
The Journal of Infectious Diseases|February 1, 1997
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infectionM Floridia, S Vella, A C Seeber, et al.
Leukemia & Lymphoma|July 29, 2016
Hodgkin's Disease in 50 Intravenous Drug Users with HIV-InfectionS Monfardini, U Tirelli, E Vaccher, et al.
Pageof 10